Research Article
Clinical Characteristics and Outcomes of Patients Hospitalized with COVID-19 at Case Hospital, Uganda
Table 5
Factors associated with mortality due to COVID-19 among the study participants.
| Variables | Odds ratio (95% CI) | |
| Age in years | 18–35 | 1.0 | | 36–40 | 1.4 (0.1–14.1) | 0.773 | ≥50 | 8.6 (1.1–69.2) | 0.042 |
| Sex | Female | 1.0 | | Male | 0.9 (0.3–2.4) | 0.805 |
| Occupation | Formal | 1.0 | | Unknown | 0.5 (0.1–2.5) | 0.395 |
| Comorbidities | None | 1.0 | | At least one | 3.2 (1.1–8.9) | 0.029 |
| Hypertension | No | 1.0 | | Yes | 3.2 (1.2–8.6) | 0.024 |
| Diabetes mellitus | No | 1.0 | | Yes | 2.9 (1.0–8.5) | 0.056 |
| HIV | No | 1.0 | | Yes | 4.1 (0.4–47.8) | 0.258 |
| Others | No | 1.0 | | Yes | 1.5 (0.3–7.3) | 0.625 |
| Symptoms at admission | Asymptomatic | 1.0 | | Symptomatic | 0.2 (0–2.8) | 0.258 |
| Vitals at admission | Systolic blood pressure | 1.0 (1.0–1.0) | 0.879 | Diastolic blood pressure | 1.0 (0.9–1.0) | 0.123 | Heart rate | 1.0 (1.0–1.0) | 0.207 | Respiratory rate | 1.1 (1.0–1.2) | 0.002 | Temperature | 1.2 (0.7–2.2) | 0.511 | Random blood sugar | 1.0 (0.8–1.2) | 0.945 | SpO2 <92 | 5.1 (1.8–14.4) | 0.002 |
| Medications | Azithromycin | 0.9 (0.3–3.1) | 0.923 | Dexamethasone | 1.2 (0.4–3.5) | 0.773 | Vitamin C | 0.7 (0.2–2.2) | 0.518 | Vitamin D | 0.7 (0.2–2.2) | 0.518 | Enoxaparin | 0.4 (0.1–1.6) | 0.219 | Zinc | 1.0 (0.3–2.8) | 0.968 | Ulinastatin | 0.9 (0.3–2.6) | 0.919 | Ivermectin | 0.2 (0.1–0.6) | 0.004 | Remdesivir | 0.2 (0.1–0.9) | 0.030 |
|
|